MLICM
SGYP

Metropolitan Life Insurance Company (MetLife)’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-87,170
Closed -$148K – 2608
2018
Q3 		$148K Hold
87,170
– – ﹤0.01% 2205
2018
Q2 		$152K Buy
87,170
+39,189
+82% +$67.8K ﹤0.01% 2109
2018
Q1 		$87.8K Sell
47,981
-35,807
-43% -$75.6K ﹤0.01% 2348
2017
Q4 		$187K Sell
83,788
-62,216
-43% -$155K ﹤0.01% 1952
2017
Q3 		$423K Sell
146,004
-9,295
-6% -$31.7K ﹤0.01% 1800
2017
Q2 		$691K Buy
155,299
+20,444
+15% +$84.3K ﹤0.01% 1462
2017
Q1 		$628K Buy
134,855
+7,195
+6% +$41.7K ﹤0.01% 1502
2016
Q4 		$777K Sell
127,660
-5,909
-4% -$30.9K 0.01% 1444
2016
Q3 		$736K Sell
133,569
-2,539
-2% -$11.9K 0.01% 1459
2016
Q2 		$517K Buy
136,108
+56,869
+72% +$193K ﹤0.01% 1669
2016
Q1 		$219K Hold
79,239
– – ﹤0.01% 2118
2015
Q4 		$449K Buy
79,239
+17,578
+29% +$107K ﹤0.01% 1686
2015
Q3 		$327K Sell
61,661
-3,982
-6% -$30.8K ﹤0.01% 1928
2015
Q2 		$545K Buy
+65,643
New +$318K ﹤0.01% 1679
2015
Q1 		– Sell
-67,438
Closed -$206K – 2549
2014
Q4 		$206K Hold
67,438
– – ﹤0.01% 2397
2014
Q3 		$188K Hold
67,438
– – ﹤0.01% 2417
2014
Q2 		$274K Hold
67,438
– – ﹤0.01% 2282
2014
Q1 		$358K Sell
67,438
-944
-1% -$5.29K ﹤0.01% 2037
2013
Q4 		$380K Buy
68,382
+2,105
+3% +$9.08K ﹤0.01% 2006
2013
Q3 		$299K Sell
66,277
-1,992
-3% -$8.93K ﹤0.01% 2108
2013
Q2 		$291K Buy
+68,269
New +$343K ﹤0.01% 2068

Other funds holding SGYP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
OCM
Opti Capital Management New York $1.39B AUM 0% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s SGYP Position: Q4 2018 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q4 2018, closing a stake of 87,170 shares — an estimated $148K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in SGYP in Q2 2013 and held it in 21 quarters. The position peaked at $777K in Q4 2016. 89 funds tracked by Wall St. Rank hold SGYP as of Q4 2018.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q4 2018 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 87,170 Synergy Pharmaceuticals, Inc Common Stock shares in Q4 2018, an estimated $148K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2013 and held it in 21 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Synergy Pharmaceuticals, Inc Common Stock position peaked at $777K in Q4 2016.
  • 89 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q4 2018.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2018, filed 14 Feb 2019.